Clinical Trial Update: Contribution of 18FDG PET-Scan in Tumour Volume Determination in Patients Operated of Breast Cancer

View source ↗

Summary

A completed clinical trial evaluating how 18F-FDG PET-Scan contributes to determining tumor volume in patients who had surgery for breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Centre Henri Becquerel | Conditions: Infiltrating Ductal Carcinoma | Status: COMPLETED